Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data
Yoshito Zamami(Tokushima University Hospital), Keisuke Ishizawa(Tokushima University Hospital), Kenshi Takechi(Tokushima University Hospital), Fuka Aizawa(Tokushima University Hospital), Yutaro Naito(Tokushima University), Keijo Fukushima(Tokushima University), Takehiro Kawashiri(Kyushu University), Daisuke Kobayashi(Kyushu University), Takahiro Niimura(Tokushima University), Hirofumi Hamano(Tokushima University Hospital), Naoto Okada(Yamaguchi University Hospital), Mitsuhiro Goda(Okayama University), Toshihiro Koyama(Okayama University), Yuki Izawa‐Ishizawa(Shikoku University), Masayuki Chuma(Nihon University), Hiromichi Fujino(Tokushima University), Kenta Yagi(Tokushima University Hospital), Takao Shimazoe(Sasaki Institute), Kôji Miyata(Tokushima University), Soichiro Ushio(Okayama University Hospital)
Cited by 23
Related Papers
Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis
|JAMA Oncology|2019|134
Activation of FP Prostanoid Receptor Isoforms Leads to Rho-mediated Changes in Cell Morphology and in the Cell Cytoskeleton
|Journal of Biological Chemistry|1999|114
Royal Jelly Ameliorates Insulin Resistance in Fructose-Drinking Rats
|Biological and Pharmaceutical Bulletin|2008|88
Trends in Polypharmacy in Japan: A Nationwide Retrospective Study
|Journal of the American Geriatrics Society|2018|81